Structure Therapeutics, Inc. Sponsored ADR GPCR 深 沪
等待开盘 06-26 09:30:00 美东时间
48.34
+0.180
+0.37%
华盛通- 最 高49.93
- 今 开48.19
- 成交量 82.90万股
- 最 低 43.985
- 昨 收 48.16
- 总市值 0
- 52周最高 94.90
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 15.80
- 委 比 -87.56%
- 总股本 --
- 历史最高 94.90
- 量 比 0.83
- 振 幅 12.34%
- 历史最低 1.10
- 每 手 1
- 风险率 20.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Less Volume, More Premium: Post-Ozempic Economics Are Killing The Quantity Model
As millions take GLP-1 drugs, packaged food giants face declining volumes while protein brands and specialty grocers win.
06-22 19:15
Structure Therapeutics Appoints Matthew Lang COO
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today announced the
04-15 04:09
Structure Therapeutics Q4 Adj. EPS $(0.36) Beats $(0.40) Estimate.
Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.40) by 9.09 percent. This is a 63.64 percent decrease over losses of $(0.22) per share
02-27 06:16
'Structure Therapeutics could be pharma's next buyout candidate'- Axios
https://www.axios.com/pro/biotech-deals/2026/01/30/structure-therapeutics-pharmas-next-buyout-glp1
01-30 23:44
What's Going On With Structure Therapeutics (GPCR) Stock Today?
Shares of Structure Therapeutics are soaring Monday after the company reported positive topline data from a weight loss drug trial.
2025-12-09 02:05
Crude Oil Falls Over 1%; Structure Therapeutics Shares Jump
U.S. stocks traded lower midway through trading, with the Dow Jones index falli...
2025-12-09 01:46
Structure Therapeutics Reports Topline Data From ACCESS Program For Aleniglipron
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight loss up to 15.3%
2025-12-08 21:07
广发医药 | COPD市场空间广阔，新型生物制剂和小分子药物迎来突破
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 文｜罗佳荣 王少喆 COPD临床负担较重，市场规模广阔。根据GOLD指...
2025-10-18 09:55
李开复也出手！创新工场等八大机构联手砸钱，AI训练赛道杀出黑马 | 每日速递
来源：IT桔子 1.基点新智获得超亿元天使轮融资 基点新智成立于2025年，是一家AI Infra云计算公司，为人工智能公司提供大批量并行训练时的系统...
2025-09-10 16:23
年度医药人盘点：36位减重&代谢领域CEO盘点（最新）
（来源：求实药社） 在肥胖与代谢性疾病成为全球公共卫生挑战的当下，中国减重代谢行业正迎来爆发式增长。作为这一领域的开拓者，减重代谢公司CEO不仅需要具备医学...
2025-08-27 12:01
